EverHint — Insider Trading Radar - November 19, 2025

November 19, 2025

Scope: Highlights from today’s Form 4 flow with emphasis on open-market buys/sells and 10%-owner activity. Focus is on dollar size, role (CEO/Chair/10% owner), and whether trades cluster around key catalysts.

10%-Owner & Control-Level Activity

CRVO — CervoMed

Who:

• John J. Alam — CEO, Director, 10% owner
• Sylvie Grégoire — Director, 10% owner

What (most recent leg):

• Buy – 10,793 shares @ $8.46 (≈**$91,309**) on Nov 17, 2025 → Form 4
• Additional director/10%-owner purchase by Sylvie Grégoire (10,807 shares; details in filing).

Context: Earlier this month CervoMed announced alignment with the FDA on the registration path for neflamapimod in dementia with Lewy bodies, plus Q3 results outlining the planned Phase 3 program. (Cervomed)

Signal: Clustered insider buying after major FDA feedback supports a constructive read-through on management’s conviction in the program.

SXI — Standex International

Who: Andy L. Nemeth — Director

What (amended filings):

• Buy – 2,000 shares @ $209.4959 (≈**$418,992**) on Aug 25, 2025
• Buy – 1,500 shares @ $205.00 (≈**$307,500**) on Aug 29, 2025
  → Disclosed today via amended Form 4s recoding the transactions as open-market purchases (code P). (TradingView)

Context: News flow frames this as a correction from prior mis-coded filings rather than fresh buying, but confirms that both August trades were true open-market purchases.

Signal: High-ticket director accumulation already in the books; today’s amended forms mainly clean up the record but still underscore past insider confidence.

AISP — Airship AI Holdings

Who: Louis Lebedin — Director, 10% owner

What:

• Buy – 50,000 shares @ $3.18 (≈**$159,000**) on Nov 18, 2025 → Form 4 (Investing.com)

Context: Multiple outlets today highlighted Lebedin’s move as a sizeable open-market add, bringing his direct holdings to 100,000 shares in this AI/analytics name.

Signal: Solid 6-figure buy from a 10% owner/director in a high-beta AI small cap — higher-risk, higher-reward but clearly backed by insider conviction.

Notable Insider Buys

RXO — RXO, Inc.

Who: Adrian Kingshott — Director (and noted holder)

What:

• Buy – 9,350 shares @ $10.75 (≈**$100,512**) on Nov 17, 2025 → Form 4 (Investing.com)

Context: Coverage notes this increases Kingshott’s stake to 91,137 shares, roughly an 11% bump in his position, in a logistics/brokerage name that’s been grinding after earlier de-rating.

Signal: Classic director “averaging in” trade — meaningful in size, but not a transformational bet. Still a supportive data point for long-onlys tracking insider alignment.

COFS — ChoiceOne Financial Services

Who: Eric E. Burrough — Director

What:

• Buy – 5,000 shares @ $28.50 (≈**$142,500**) on recent date per Form 4 (cash open-market purchase).

Context: No major new headlines today; this looks like a straightforward add in a community-/regional-bank-style name.

Signal: Steady, mid-six-figure director buy in a smaller financial — most relevant for regional-bank stock pickers looking for alignment in quieter names.

STRZ / SRTS and Other Smaller Buys

• STRZ — Jeffrey Hirsch, President & CEO, reported an open-market buy (size per filing).
• SRTS — Joseph C. Sardano, CEO/Director, also filed a purchase.
• Additional modest buying in regional/financial names rounds out today’s tape.

Signal: These are smaller, idiosyncratic adds — more interesting as part of a pattern over time than as single-day catalysts.

Notable Insider Sells

VICR — Vicor Corp.

Who: Andrew D’Amico — Director (and, per some reports, 10% owner)

What:

• Sale – 2,000 shares @ $87.69 (≈**$175,380**) on Nov 17, 2025, tied to option exercise and sale under a Rule 10b5-1 plan. (Investing.com Nigeria)

Context: Comes after a very strong run in the stock and earlier November sales; recent coverage notes Vicor’s big EPS beat and strong 6-month price performance.

Signal: Looks like structured profit-taking after a big move rather than a fresh negative signal — but bulls may still flag the director moving to zero direct holdings.

BBAI — BigBear.ai Holdings

Who: Dorothy D. Hayes — Director

What:

• Sale – 22,000 shares @ $6.085 (≈**$133,870**) on Nov 18, 2025 → Form 4 (Investing.com)

Context: Part of an ongoing pattern of insider selling in this AI/ML name following its earnings and acquisition headlines earlier in November.

Signal: Given prior sales and high volatility, this reads as continuation of de-risking at elevated levels, not a one-off event.

BKNG — Booking Holdings

Who: Glenn D. Fogel — CEO, President & Director
What:

• Recent small-block sales (e.g., ~170–400 shares, ≈**$0.9–2.0M**) on Nov 17, 2025, all under a pre-arranged 10b5-1 trading plan. (Investing.com)

Context: Travel giant with a premium valuation; insider sales are plan-driven and modest relative to Fogel’s remaining ~21k+ shares.

Signal: Reads as routine diversification, not thesis-changing.

AFL — Aflac

Who: Joseph L. Moskowitz — Director

What:

• Sale – 786 shares @ $113.745 (≈**$89,404**) on Nov 17, 2025 → Form 4 (Investing.com)

Context: Small trim around levels that recent commentary describes as close to fair value, following board actions on buybacks and dividend increases earlier in November.

Signal: Low-signal, incremental profit-taking in a mature, capital-return-heavy insurer.

Quick Take

• Strongest bullish clusters:
  • CRVO — multiple 10%-owner/insider buys after FDA alignment + Q3 update.
  • AISP — 10% owner/director Louis Lebedin’s $159K buy anchors today’s AI-theme activity. (Investing.com)
• High-ticket, but back-dated:
  • SXI director Nemeth’s August buys are re-coded as purchases today via Form 4/A — important for historical context, but not fresh capital entering. (TradingView)
• Mid-cap logistics & regional banks:
  • RXO and COFS show six-figure director buys, useful for investors screening for conviction in less crowded corners of the market. (Investing.com)
• Sells skew “orderly”:
  • VICR, BBAI, BKNG, AFL transactions are mostly 10b5-1/plan-driven or small trims after strong runs or stable valuations — more about portfolio management than red alerts. (Investing.com Nigeria)

Independent research. No hype, no pumps, no paid promotions — just clean, data-driven signals and concise context.